♟️ Thursday 21 May 2026 Thu, 21 May 2026

Nationwide Building Society reported a 9% rise in underlying profit to £2.026 billion for FY26, driven by market-leading mortgage growth and successful Virgin Money integration, while maintaining robust capital and liquidity positions.

Industrial Minerals Ltd confirms its acquisition of the Laverton Gold Portfolio, associated drill data, and a $3 million placement are material disclosures, responding to ASX queries and affirming continuous disclosure compliance.

A landmark regulatory agreement between Canada and Alberta suspends federal emissions abatement deadlines and establishes a stable carbon pricing framework, enhancing KALiNA Power’s Alberta projects and data centre opportunities.

Equity Trustees Superannuation Limited (ETSL) will contest ASIC's Federal Court civil proceedings related to the First Guardian Master Fund, where member losses total around $70 million. The trustee insists it acted within its fiduciary duties amid ongoing liquidation efforts.

Findi Limited lowers its FY26 operating revenue and EBITDA guidance, citing integration costs and funding delays, but reports operational improvements following a $25 million equity raise and appoints a new Chief Commercial Officer.

Little Green Pharma (ASX:LGP) posted a 15.3% revenue increase to AUD 42.5 million in FY2026, driven by European market expansion, yet recorded a $1.4 million loss after tax impacted by significant inventory write-downs.

Energy One Limited reveals solid sales momentum and strategic AI integration under new CEO Ben Tranier, despite slight ARR timing delays and ongoing market complexity.

Nex Metals Explorations and the Wangkatja Tjungula Aboriginal Corporation have formalised a joint venture to combine WTAC’s capital and cultural knowledge with Nex Metals’ technical expertise to pursue gold projects in Western Australia.

Island Pharmaceuticals has appointed Raymond Taylor, a former BioCryst executive with deep Galidesivir expertise and US government funding experience, to accelerate development and procurement efforts for its broad-spectrum antiviral amid rising viral threats.

Argenica Therapeutics has passed a critical FDA genotoxicity test for its stroke drug ARG-007, advancing its IND application and edging closer to Phase 2b clinical trials in the US and Australia.

Eden Innovations appoints former European Parliament member Antanas Guoga to lead EdenShield’s push into European defence and critical infrastructure markets amid surging regional security spending.

L1 Long Short Fund Limited (ASX:LSF) has declared a fully franked 3.7 cent dividend, continuing a trend of rising payouts amid a standout 44.7% net return over the past year, significantly outperforming the ASX200AI benchmark.

Lion Rock Minerals has brought in a seasoned leadership team from Sierra Rutile to spearhead development at its Minta Rutile and Monazite Project in Cameroon, supported by a $2 million capital raise.

Northern Star Resources is preparing for a leadership change as Managing Director Stuart Tonkin announces his intention to step down in the first quarter of FY27 after 13 years at the helm. The Board has initiated a global search to find his successor.

Arafura Rare Earths has committed to constructing the Nolans Rare Earths Project, Australia's first fully integrated ore-to-oxide operation, backed by binding offtake deals and sovereign financing. Construction is slated to start in September 2026, positioning Nolans as a strategic node in global rare earth supply chains.

Australian Agricultural Company (ASX:AAC) defies North Queensland floods to deliver a 23% jump in operating profit, driven by strong beef pricing and herd valuation gains.

Ventia Services Group reported a strong FY25 with revenue of $6.1 billion and 13% NPATA growth, while CEO Dean Banks announced his planned departure later this year. The company reaffirmed its FY26 guidance and highlighted growth opportunities in Defence, Digital Infrastructure, Energy, and Water.

AFT Pharmaceuticals posted a 22% revenue jump to NZ$254.7 million and a 39% increase in operating profit to a record NZ$24.4 million for FY26, exceeding guidance. The company targets over NZ$300 million revenue for FY27, fueled by international expansion and a deepening R&D pipeline.

TruScreen Group Limited has kicked off a NZ$2.9 million capital raising combining a NZ$1 million placement and a NZ$1.94 million rights issue to fund its global expansion and regulatory compliance efforts. The company reported a 42% jump in product sales for FY2026 and is targeting major public health programs across 14 countries.

Turners Automotive Group has posted a record $63.2 million normalised NPBT for FY26, advancing its $65 million NPBT target to FY27 and setting sights on $100 million by FY31 amid solid finance and retail momentum.

BLIS Technologies posted a 16% revenue increase to $14.7 million in FY26, resolving a key intellectual property dispute and expanding strategic partnerships, including an extended Probi AB agreement that now covers pet nutrition.

Investore Property Limited reported a resilient FY26 with 14% portfolio growth driven by acquisitions, maintained dividends, and proactive capital management amid inflationary pressures.